SCHEMBL30033459

SCHEMBL30033459

O=c1[nH]c2ccc(OC(F)(F)F)cc2c(=O)n1-c1cncc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ KIF11 P52732 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.42
▸ CRHBP P24387 1/20 0.42
▸ CRHR2 Q13324 1/20 0.42
▸ NPEPPS P55786 1/20 0.41
▸ IDO1 P14902 2/20 0.41
▸ DDR1 Q08345 2/20 0.40
▸ HTT P42858 1/20 0.38
▸ CYP17A1 P05093 1/20 0.36
▸ CCNT1 O60563 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ HTR1A P08908 1/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ HTR6 P50406 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30033456 0.92 HSD17B10 (0.41) PKMHSD17B10KIF11KDM4ECRHBP
SCHEMBL30033007 0.88 HSD17B10 (0.43) PKMHSD17B10KDM4ENPEPPSHTT
SCHEMBL30034581 0.86 HSD17B10 (0.58) PKMHSD17B10KDM4ENPEPPSHTT
SCHEMBL30032902 0.84 HSP90AA1 (0.48) KIF11KDM4ENPEPPSDDR1HTT
SCHEMBL27379210 0.83 IDO1 (0.39) PKMHSD17B10KIF11KDM4ENPEPPS
SCHEMBL30034350 0.82 NPEPPS (0.42) PKMHSD17B10KIF11KDM4ENPEPPS
SCHEMBL31509793 0.81 NPEPPS (0.57) PKMHSD17B10KDM4ENPEPPSHTT
SCHEMBL30032168 0.80 NPEPPS (0.49) PKMHSD17B10KDM4ENPEPPSIDO1
SCHEMBL30033042 0.80 KDM4E (0.57) PKMHSD17B10KDM4ENPEPPSHTT
SCHEMBL30034219 0.80 NPEPPS (0.43) PKMHSD17B10KIF11KDM4ENPEPPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022224223-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES NOVARTIS AG (CH) 2022-10-27 — — WO disclosed
Send feedback